{
  "Variants Include": [
    {
      "Gene": "a-synuclein",
      "variants": [
        {
          "HGVS": "NM_005364.4:c.640delC",
          "cDNA Change": {
            "transcript": "NM_005364.4",
            "ref": "C",
            "alt": "del",
            "position": "640"
          },
          "Protein Change": {
            "ref": "Gly",
            "alt": "Stop",
            "position": "214"
          },
          "Description in input context": "c.640delC (p.G215*), a single point mutation related to Parkinson's disease."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005406"
  },
  "Experiment Method": [
    {
      "Assay Method": "Single-molecule FRET (smFRET)",
      "Material used": {
        "Material Source": "Small unilamellar vesicles (SUVs)",
        "Material Name": "a-synuclein",
        "Description": "The experiment was conducted using a-synuclein bound to SUVs."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_005364.4:c.640delC",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The smFRET study showed that the bent and helical a-synuclein structures could coexist in the presence of SUVs, and different conditions or binding partners can promote the adoption of bent or extended helical structures."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "The smFRET study was performed with multiple biological replicates."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "N/A"
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type a-synuclein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "N/A"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "N/A"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N/A"
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N/A",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N/A",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "No"
      }
    }
  ]
}